Article Related content Article metrics Rapid responses Response Rapid Response: Below is the exchange of letters between Jon Jureidini and GlaxoSmithKline between March and May 2014. Competing interests: As declared in the article (BMJ 2013;347:f6754). 29 July 2014 Peter Doshi associate editor The BMJ London WC1H 9JR, UK
Rapid Response:
Below is the exchange of letters between Jon Jureidini and GlaxoSmithKline between March and May 2014.
Competing interests: As declared in the article (BMJ 2013;347:f6754).